As CD44 interacts with and enhances TGF-βRI activity [38, 39], our results suggest that the CHI3L1/CD44/IL-13Rα2 axis regulates the downstream effectors of driver oncogenes that contribute to GC survival, invasion, and metastasis. This evidence concerns the gene IL13RA2 and gastric cancer.